SIX •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSIX
Market Capitalization2,448.63 mln
Earnings Date07/24/2026
EPS
14.55
Robust
P / E
3.00
Deeply undervalued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
3.18
Highly suspicious
Relative Strength
50
/ 100
In line with market
Debt / Equity
0.00
Debt-free
Business Description
Founded in Switzerland in 1993, BB Biotech AG is an investment fund run by Bellevue Asset Management AG. The fund buys shares in publicly traded companies around the world that develop medicines and diagnostic tools using biotechnology. Investment decisions are guided by in-depth research into each company's underlying business fundamentals.
